solomo.ai

KRM Ayurveda Ltd (KRMAYURVED) — shareholding pattern, promoter holding, financials and share price

About KRM Ayurveda Ltd (KRMAYURVED)

KRM Ayurveda Ltd operates in the Hospital industry, within the Healthcare sector. It trades on the NSE as KRMAYURVED and on the BSE under scrip code 95900. Its ISIN is INE1MTV01019.

Incorporated on 3 September 2019, KRM Ayurveda Ltd. is operating a network of hospitals and clinics across multiple cities in India. [1]

Listed peers in Hospital: Asarfi Hospital Ltd, Hannah Joseph Hospital Ltd, Lotus Eye Hospital & Institute Ltd, Aashka Hospitals Ltd, Abate As Industries Ltd, Fortis Malar Hospitals Ltd.

Valuation & Returns

10 Jul 2026

At ₹259 a share on 10 Jul 2026, KRM Ayurveda Ltd (KRMAYURVED) was valued at a price-to-earnings ratio of 25.6x against an industry P/E of 61.73x and a price-to-book of 4.58x on a book value of ₹56.55 per share. Solomo computes return on equity of 17.54% and return on capital employed of 26.13% from filed results.

P/E
25.6x
Industry P/E
61.73x
P/B
4.58x
Book value / share
₹56.55
ROE
17.54%
ROCE
26.13%
ROA
16.39%
Debt / equity
0x
Dividend yield
0%
EBITDA margin
30.48%
52-week range
₹156.15 – ₹271

Ratios are computed from filed results and the last recorded price. Not investment advice.

Financial Performance

Mar 2026

In the year ended Mar 2026, KRM Ayurveda Ltd (KRMAYURVED) reported revenue of ₹102 crore, net profit of ₹20 crore and earnings per share of ₹9.46. That compares with revenue of ₹77 crore and net profit of ₹12 crore in Mar 2025. Figures are standalone, as filed with the exchanges.

In the quarter ended Mar 2026, revenue was ₹53 crore and net profit ₹12 crore (standalone).

Standalone annual results for KRM Ayurveda Ltd (KRMAYURVED), Mar 2023 to Mar 2026. Revenue and net profit in ₹ crore; EPS in ₹ per share.
MetricMar 2023Mar 2024Mar 2025Mar 2026
Revenue (₹ cr)896777102
Net profit (₹ cr)831220
EPS (₹)5,066.672,273.33806.679.46
Compound annual growth for KRM Ayurveda Ltd (KRMAYURVED). Stock price CAGR is price return and excludes dividends.
Measure1Y
Sales growth13.98%
Profit growth254.84%

Ownership Summary

Mar 2026

As of Mar 2026, promoters hold 69.15% of KRM Ayurveda Ltd (KRMAYURVED). Market capitalisation was ₹551 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2026.

Largest disclosed public shareholders in Mar 2026: PINE OAK GLOBAL FUND 2.01%, MANSI SHARE & STOCK BROKING PRIVATE LIMITED 1.93%, SHANNON ADVISORS PRIVATE LIMITED 1.07%, AARTH AIF GROWTH FUND 1.05%. Only stakes above the 1% disclosure threshold are named in filings.

QuarterPromoterPledgedFIIDIIPublic
Mar 202669.15%----
Every quarter since Mar 2026 Filing data, not investment advice.